

The NSW Branch is delighted to invite you to their 2023 Symposium ‘Pills and Skills: Pharmacy Practice in the Intensive Care Unit’, an event designed to provide an overview of pharmacy practice in the Intensive Care Unit (ICU).
This symposium aims to equip pharmacists with the knowledge and skills necessary to gain confidence in the specialised field of critical care. Whether you are an enthusiastic pharmacist looking to gain confidence in critical care or an experienced critical care pharmacist seeking to hear from influential speakers in this area, this event offers valuable insights for all.
Don't miss this opportunity to expand your knowledge in critical care. Register now for the Pills and Skills: Pharmacy Practice in the Intensive Care Unit symposium!
This is an in-person event!
Asad Patanwala | Chair of Clinical Pharmacy | Royal Prince Alfred Hospital | University of Sydney
Professor Patanwala is Chair of Clinical Pharmacy and is jointly based at the University of Sydney School of Pharmacy and the Royal Prince Alfred Hospital (RPAH). He is a registered pharmacist in both the United States and Australia and is a Board Certified Critical Care Pharmacist (BCCCP). He completed his Doctor of Pharmacy at Drake University and worked at the University of Chicago Hospital for a few years. Subsequent to this he completed a pharmacy residency and a specialized residency in critical care at the University of Arizona Medical Center. He then completed a Masters in Public Health (biostatistics) and served as a clinician (ICU / emergency department) academic at the University of Arizona. He has been involved in international clinical trials (REMAP-CAP) and clinical practice guidelines from the Society of Critical Care Medicine. He serves on the Clinical Trials Sub-Committee for the Sydney Local Health District and Drug Committee for RPAH. He has published 180+ journal articles and book chapters including those in NEJM, JAMA, Annals of Internal Medicine, Intensive Care Medicine, and Crit Care Med
Dr David Gattas | Clinical Associate Professor, Sydney Medical School, University of Sydney Senior Staff Specialist, Intensive Care Unit | Royal Prince Alfred Hospital | Clinical Associate Professor | Sydney Medical School | The University of Sydney
Associate Professor David Gattas is a senior staff intensivist at Royal Prince Alfred Hospital (RPA). He trained at the University of Sydney and its associated teaching hospitals before completing a 2-year clinical and research fellowship at Sunnybrook Medical Centre in Toronto, Canada. Since then, he has accumulated over twenty years of clinical experience as an intensivist at RPA. He maintains a strong professional interest in clinical research, with an emphasis on multicentric randomised controlled trials. He has published on a range of subjects, with a concentration on resuscitation fluids and renal replacement therapy. He has served for many years on RPA’s Human Research Ethics Committee clinical trial subcommittee and founded the hospital’s rapid response system in 2008 which he continues to help manage as Chair of that hospital committee. He learned very early in his career that intensive care is a team sport where all craft groups are needed to work well together to achieve the best clinical outcomes. As a big fan of critical care pharmacists, he is delighted to be invited to speak today and his only complaint about critical care pharmacy support in the ICU is that there needs to be more of it.
Dr. Arwa Abu Sardaneh | Critical Care Pharmacist, Royal Prince Alfred Hospital, Sydney, NSW
Arwa is a critical care pharmacist at Royal Prince Alfred hospital and is an associate academic at the School of Pharmacy, University of Sydney.
She recently completed her PhD on the role of metaraminol and other vasopressors in critically ill patients with shock.
Grainnie Hughes |
B. Pharm Clin. Dip. Member SPHA, ICU Pharmacist, Canberra Health Services
Grainne studied Pharmacy in Robert Gordon University in Aberdeen, Scotland and worked in the Royal Liverpool Hospital for 3 years before moving to Australia. Since then, most of her time has been spent working in the Canberra Hospital ICU with short periods of time in Calvary Public Hospital Bruce and the Alfred ICU in Melbourne.
The program addresses pharmacist competency standards, including:
Standard 1.4.1 Adopt a scope of practice consistent with competence
Standard 1.4.3 Acquire and apply practice expertise
Standard 3.1.2 Assess medication management practices and needs
Standard 3.2.1 Administer medicines
Standard 3.2.2 Provide primary care and promote judicious use of medicines
Standard 3.3.1 Undertake a clinical review
Standard 3.3.2 Apply clinical review findings to improve health outcomes
Standard 4.3.3 Encourage, influence and facilitate change
Standard 4.7.6 Work across service delivery boundaries
Standard 5.3.3 Apply research evidence into practice’
(National Competency Standards Framework for Pharmacists in Australia, 2016)
CPD Accreditation
This activity has been accredited for 2 hours of Group-1 CPD and 3 hours of Group-2 CPD (for a total of 8 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan.
The accreditation number is S2023/63.
All registration rates include GST
SHPA are in no way responsible for any connectivity issues as a result of the participants internet connection or hardware issues or other external factors impacting the internet, that are out of SHPA’s control.
The SHPA website contains guidelines, policies, procedures, information and various data which have been prepared by SHPA. Whilst the information contained on this site has been reviewed with due care, SHPA does not warrant or imply that the information is free from errors or omissions. Whilst the information is considered to be true and correct at the date of publication, changes in circumstances after publication may impact on the accuracy of the information.
The information presented on the website is made available on the understanding that SHPA, its employees and agents shall have no liability to the users for any loss, damage, cost or expenses arising from the use of the information through either action or inaction based on material on this site.
SHPA provides links from the SHPA website to sites that might be useful information sources to users of the website. Providing this information in no way assumes responsibility for the content contained on those websites.